Cross Annamaria Calleo is categorized under Internal Medicine Doctors in West Harrison, NY and active since 2010.
Cross Annamaria Calleo was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Abdeljaber Basil R at the company’s single location by writing to 210 Westchester Avenue, West Harrison, New York NY 10604 or by phoning (914) 682-6560. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cross Annamaria Calleo |
| Contact Person: | Abdeljaber Basil R |
| Address: | 210 Westchester Avenue, West Harrison, New York 10604 |
| Phone Number: | (914) 682-6560 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Cross Annamaria Calleo was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Abdeljaber Basil R for inquiries that concern Cross Annamaria Calleo by calling the company number (914) 682-6560, as your correspondence is most welcome. Additionally, the physical location of the single location of Cross Annamaria Calleo can be found at the coordinates 41.03075,-73.741739 as well as the street address 210 Westchester Avenue in West Harrison, New York 10604.
For its online presence, you may visit Cross Annamaria Calleo’s website at and engage with its social media outlets through on Twitter and on Facebook.